Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.
In recent decades, the microbiome has emerged as a dynamic ecosystem, an “invisible organ” that plays a crucial role in systemic health and, more recently, in ophthalmology.When naturally balanced, ...
As of Thursday, December 18, Anteris Technologies Global Corp.’s AVR share price has surged by 12.03%, which has investors ...
Medical Device Network on MSN
What 2025 reveals about medtech’s next leap in 2026
No one can predict what the medical device industry will look like in 2026. Still, the events of 2025 provide meaningful ...
Manipal Hospital Bhubaneswarhas successfully performed a highly complex Transcatheter Aortic Valve Implantation (TAVI) on an ...
Aortic stenosis is a narrowing of the aortic valve, which connects the heart to the rest of the body. It affects millions of ...
Background Predicting progression to aortic valve replacement (AVR) in moderate aortic stenosis (AS) is challenging. This ...
Francisco J. Rivera Rosario is a science communications editor experienced in developing all types of science content including, scientific journal articles, infographics, medical educational videos, ...
From first-of-its-kind cardiac procedure milestones to new AI and technology integrations, here are 15 firsts that happened in the cardiology space, as reported by Becker’s in 2025. Note: This list is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback